FindTrial
Sign In

Copmarison of two ultrasound-guided nerve block methods control the pain of patients undergoing hernia surgery

Copmarison of ultrasound-guided transabdominus plane block and ilioinguinal-iliohypogastric nerve blocks to control the pain of patients undergoing open inguinal hernia surgery

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014030816888N1
Enrollment
54
Registered
2014-12-25
Start date
2014-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia. Inguinal hernia

Interventions

Intervention 1: Bupivacaine 0.2%, 15 cc (30 mg), made in MYLAN
Saint-priest France. Ultrasound-guided, injection in 2 cm above the highest point of right iliac crest. Intervention 2: Bupivacaine 0.2%, 15 cc (30 mg), MYLAN
Saint-priest France. Ultrasound-guided, nerve block at 2 cm above and 2 cm interior the anterior-superior iliac crest.
Treatment - Drugs
Bupivacaine 0.2%, 15 cc (30 mg), made in MYLAN
Saint-priest France. Ultrasound-guided, injection in 2 cm above the highest point of right iliac crest.
Bupivacaine 0.2%, 15 cc (30 mg), MYLAN
Saint-priest France. Ultrasound-guided, nerve block at 2 cm above and 2 cm interior the anterior-superior iliac crest.

Sponsors

Iran University of Medical Sciences, Vice Chancellor for Research
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Men between 20 to 70 years old 2. Elective surgery Exclusion criteria: 1. Infection in surgery site 2. Sensitivity to study medications 3. Chronic use of non steroidal anti inflammatory drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sedation level. Timepoint: Immediately after recovery and in hours 4, 8, 12, and 24 after surgery. Method of measurement: Ramsay score.;Pain intensity. Timepoint: Immediately after recovery and in hours 4, 8, 12, and 24 after surgery. Method of measurement: Visual analogue scale.;Need for additional opioid. Timepoint: Immediately after recovery and in hours 4, 8, 12, and 24 after surgery. Method of measurement: Yes or no.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoraya Nik-nejadi

Iran University of Medical Sciences

tab4412@yahoo.com+98 21 8670 2503

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026